SEC Form 4 · accession 0000899243-18-023312
Vyome Holdings, Inc · HIND
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Arnold L Oronsky
10% Owner
Khaled Nasr
10% Owner
Gilbert H Kliman
10% Owner
INTERWEST PARTNERS X LP
10% Owner
InterWest Management Partners X, LLC
10% Owner
Keval Desai
10% Owner
Period of report
Aug 23, 2018
Accepted (ET)
Aug 27, 2018 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001427570
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 23, 2018 | P | 1,098,901 | $1.82 | A | 3,552,239 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person purchased these shares directly from the issuer in a private placement.
- F2These securities are held of record by InterWest Partners X, L.P. ("IW10"). InterWest Management Partners X, LLC ("IMP10") is the general partner of IW10 and has sole voting and investment control over the shares owned by IW10. Gilbert H. Kliman, and Arnold L. Oronsky are Managing Directors of IMP10 and, Keval Desai and Khaled A. Nasr, and are Venture Members of IMP10. Douglas Fisher, a Member of IMP10 is also a Director of the Issuer, and when required, files a separate Form 4 in his own name. All Reporting Persons disclaim beneficial ownership of shares of Obalon Therapeutics, Inc. stock held by IW10, except to the extent of their respective pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1944, or otherwise, any of the Reporting Persons are the beneficial owner of all of the equity securities covered by this statement.